Jeffry R. Keyes's most recent trade in Quantum-Si Incorporated - Ordinary Shares - Class A was a trade of 8,624 Class A Common Stock done at an average price of $1.6 . Disclosure was reported to the exchange on June 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quantum-Si Incorporated - ... | Jeffry R. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.61 per share. | 23 Jun 2025 | 8,624 | 1,179,570 | - | 1.6 | 13,918 | Class A Common Stock |
| Quantum-Si Incorporated - ... | Jeffry R. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.39 per share. | 21 Mar 2025 | 8,626 | 1,188,194 | - | 1.4 | 11,951 | Class A Common Stock |
| Quantum-Si Incorporated - ... | Jeffry R. Keyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 750,000 | 1,196,820 | - | 0 | Class A Common Stock | |
| Cns Pharmaceuticals Inc | Jeffry R. Keyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2024 | 17,500 | 62,928 | - | - | Option to purchase common stock | |
| Cns Pharmaceuticals Inc | Jeffry R. Keyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2024 | 17,500 | 80,428 | - | - | Restricted Stock Units | |
| Cns Pharmaceuticals Inc | Jeffry R. Keyes | Director | Grant, award, or other acquisition of securities at price $ 0.30 per share. | 07 Mar 2022 | 11,100 | 11,100 (0%) | 0% | 0.3 | 3,294 | Common Stock |
| Cns Pharmaceuticals Inc | Jeffry R. Keyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 32,000 | 178,559 | - | - | Option to purchase common stock |